Ability of Recombinant Human Catalase to Suppress Inflammation of the Murine Lung Induced by Influenza A

Influenza A virus pandemics and emerging antiviral resistance highlight the urgent need for novel generic pharmacological strategies that reduce both viral replication and inflammation of the lung. We have previously investigated the therapeutic efficacy of recombinant human catalase (rhCAT) against...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xunlong, Shi, Zhihui, Huang, Hai, Zhu, Hongguang, Zhou, Pei, Zhu, Haiyan, Ju, Dianwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087580/
https://www.ncbi.nlm.nih.gov/pubmed/24385240
http://dx.doi.org/10.1007/s10753-013-9800-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087580/
https://www.ncbi.nlm.nih.gov/pubmed/24385240
http://dx.doi.org/10.1007/s10753-013-9800-2

Ejemplares similares